DIAGNOSIS OF ENDOCRINE DISEASE: Biochemical diagnosis of phaeochromocytoma and paraganglioma
Authors:
- J W M LendersJLJ W M Lenders
- H J L M TimmersHTH J L M Timmers
- 1 March 2014
- journal article
- review article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 170 (3) , R109-R119
Abstract
Adrenal phaechromocytomas and extra-adrenal sympathetic paragangliomas (PPGLs) are rare neuroendocrine tumours, characterised by production of the catecholamines: noradrenaline, adrenaline and dopamine. Tumoural secretion of catecholamines determines their clinical presentation which is highly variable among patients. Up to 10–15% of patients present entirely asymptomatic and in 5% of all adrenal incidentalomas a PPGL is found. Therefore, prompt diagnosis of PPGL remains a challenge for every clinician. Early consideration of the presence of a PPGL is of utmost importance, because missing the diagnosis can be devastating due to potential lethal cardiovascular complications of disease. First step in diagnosis is proper biochemical analysis to confirm or refute the presence of excess production of catecholamines or their metabolites. Biochemical testing is not only indicated in symptomatic patients but also in asymptomatic patients with adrenal incidentalomas or identified genetic predispositions. Measurements of metanephrines in plasma or urine offer the best diagnostic performance and are the tests of first choice. Paying attention to sampling conditions, patient preparation and use of interfering medications is important, as these factors can largely influence test results. When initial test results are inconclusive, additional tests can be performed, such as the clonidine suppression test. Test results can also be used for estimation of tumour size or prediction of tumour location and underlying genotype. Furthermore, tumoural production of 3-methoxytyramine is associated with presence of an underlyingSDHBmutation and may be a biomarker of malignancy.Keywords
This publication has 65 references indexed in Scilit:
- SomaticHIF2AGain-of-Function Mutations in Paraganglioma with PolycythemiaNew England Journal of Medicine, 2012
- Cardiovascular manifestations of phaeochromocytomaJournal Of Hypertension, 2011
- Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paragangliomaHuman Molecular Genetics, 2011
- Measurements of Plasma Methoxytyramine, Normetanephrine, and Metanephrine as Discriminators of Different Hereditary Forms of PheochromocytomaClinical Chemistry, 2011
- Metastatic ParagangliomaSeminars in Oncology, 2010
- Catecholamine metabolomic and secretory phenotypes in phaeochromocytomaEndocrine-Related Cancer, 2010
- The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine TumorsPancreas, 2010
- Low Sensitivity of Glucagon Provocative Testing for Diagnosis of PheochromocytomaThe Journal of Clinical Endocrinology & Metabolism, 2010
- Biochemically Silent Abdominal Paragangliomas in Patients with Mutations in theSuccinate Dehydrogenase Subunit BGeneThe Journal of Clinical Endocrinology & Metabolism, 2008
- Adverse Drug Reactions in Patients with PhaeochromocytomaDrug Safety, 2007